1-008 - Rationale and Design of two Phase 3 Randomized Controlled Trials (Evolution RMS 1&2) Evaluating the Brutons Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis
Evobrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: 1-008 - Rationale and Design of two Phase 3 Randomized Controlled Trials (Evolution RMS 1&2) Evaluating the Brutons Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis ### Output: Evobrutinib